As the healthcare M&A market accelerates in 2026, the margin for error in practice acquisition has vanished. Successful buyers and disciplined sellers both need a “gold standard” financial lens to protect value, preserve credibility, and create a smoother close.
The cornerstone of a secure acquisition is Step 3 of the 10-step guide: evaluating financials and valuation through a three-year deep-dive into Quality of Earnings (QoE), revenue cycle performance, and realistic normalization adjustments. The American Hospital Association (AHA) notes transparency is key to merger success.
Strategic Due Diligence Checklist
To achieve capital optimization, evaluate these critical areas before closing:
✅ Payer Mix Analysis: Audit the ratio of Commercial to CMS reimbursements.
✅ EBITDA Normalization: Strip out non-recurring expenses to find the true cash flow.
✅ Accounts Receivable Quality: Analyze the aging report for uncollectible debt.
✅ Compliance Risk: Verify coding accuracy to avoid OIG clawbacks.
Step 3: Evaluate Financials and Valuation
For buyers, this step is about confirming what the business truly earns and what risks are hiding behind the headline price. For sellers, it is about defending value with clean documentation, credible add-backs, and a financial story that can withstand scrutiny.
✅ Reasonable seller add-backs may include one-time legal fees, owner-specific perks, or unusual startup costs tied to a non-recurring event.
✅ Questionable seller requests deserve extra review because they can artificially inflate EBITDA. A seller may push aggressive add-backs to support a higher valuation multiple, offset margin pressure, or reframe recurring overhead as “temporary.”
✅ Cautionary tasks should include verifying that claimed non-recurring expenses are truly one-time, tracing management adjustments to source documents, and testing whether staffing, marketing, repairs, or consulting costs are likely to return after closing. The Institute for Healthcare Improvement (IHI) consistently emphasizes operational discipline, and that same discipline matters in transaction diligence.
Optimizing Accounts Receivable and AR-Backed Working Capital
During a transition, traditional bank financing often fails to provide the immediate liquidity needed to maintain operations. AR-Backed Working Capital can serve as the bridge between signed deal economics and real-world cash flow, helping both buyers and sellers navigate timing gaps without disrupting operations.
AR-Backed Working Capital and Accounts Receivable for M&A Bridging
Unlike traditional factoring, our non-notification lending model keeps the practice owner in full control of billing and collections. White Coat Financial Partners does not take possession of receivables, contact patients, or intervene in the billing process. By lending against the aggregate Accounts Receivable rather than individual claims, White Coat Financial Partners provides the financial peace of mind necessary to bridge the gap between acquisition, valuation adjustments, and normalized revenue cycles. Repayment is structured to align with cash flow, with no compounding factor fees or open-ended discount rates, creating clarity and strategic advantage for both solo practices and multi-location groups. This supports standards from the Institute for Healthcare Improvement (IHI).
Unlock your potential today. Contact White Coat Financial Partners for expert M&A support and customized financing.
Web: https://thewhitecoatadvantage.com | Phone: 910-688-5077